All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 0.25 | 78.7 | 78.4 | 79.1 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 0.50 | 70.9 | 70.5 | 71.3 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 0.75 | 66.0 | 65.6 | 66.3 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 1.00 | 62.2 | 61.8 | 62.6 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 1.50 | 56.9 | 56.5 | 57.3 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 2.00 | 53.6 | 53.1 | 54.0 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 2.50 | 51.0 | 50.5 | 51.4 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 3.00 | 49.1 | 48.6 | 49.5 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 4.00 | 46.2 | 45.8 | 46.7 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 5.00 | 44.4 | 43.9 | 44.9 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 6.00 | 43.2 | 42.7 | 43.7 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 7.00 | 42.2 | 41.7 | 42.8 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 8.00 | 41.5 | 40.9 | 42.1 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 9.00 | 41.5 | 40.8 | 42.2 |
All cancers except NMSC (C00-C97 ex C44) | 1994-1998 | cohort | Both | 15-99 | 10.00 | 41.5 | 40.8 | 42.3 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 0.25 | 81.9 | 81.6 | 82.2 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 0.50 | 75.0 | 74.7 | 75.4 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 0.75 | 70.6 | 70.2 | 71.0 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 1.00 | 67.3 | 66.9 | 67.6 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 1.50 | 62.7 | 62.3 | 63.1 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 2.00 | 59.5 | 59.1 | 59.9 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 2.50 | 57.1 | 56.7 | 57.5 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 3.00 | 55.4 | 55.4 | 55.4 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 4.00 | 52.8 | 52.4 | 53.3 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 5.00 | 51.1 | 50.6 | 51.5 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 6.00 | 49.9 | 49.4 | 50.4 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 7.00 | 48.8 | 48.3 | 49.4 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 8.00 | 48.2 | 47.6 | 48.7 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 9.00 | 47.7 | 47.1 | 48.3 |
All cancers except NMSC (C00-C97 ex C44) | 1999-2003 | cohort | Both | 15-99 | 10.00 | 47.4 | 46.7 | 48.1 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 0.25 | 85.8 | 85.6 | 86.1 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 0.50 | 79.9 | 79.6 | 80.2 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 0.75 | 75.9 | 75.6 | 76.2 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 1.00 | 72.8 | 72.4 | 73.1 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 1.50 | 68.5 | 68.1 | 68.8 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 2.00 | 65.6 | 65.2 | 66.0 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 2.50 | 63.6 | 63.3 | 64.0 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 3.00 | 62.0 | 62.0 | 62.0 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 4.00 | 59.5 | 59.1 | 59.9 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 5.00 | 57.8 | 57.4 | 58.2 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 6.00 | 56.4 | 56.0 | 56.9 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 7.00 | 55.5 | 55.0 | 56.0 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 8.00 | 54.9 | 54.4 | 55.4 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 9.00 | 54.6 | 54.0 | 55.2 |
All cancers except NMSC (C00-C97 ex C44) | 2004-2008 | cohort | Both | 15-99 | 10.00 | 54.4 | 53.6 | 55.2 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 0.25 | 88.4 | 88.1 | 88.6 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 0.50 | 83.6 | 83.4 | 83.9 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 0.75 | 80.2 | 79.9 | 80.4 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 1.00 | 77.4 | 77.1 | 77.7 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 1.50 | 73.2 | 72.9 | 73.5 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 2.00 | 70.3 | 70.0 | 70.7 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 2.50 | 68.2 | 67.8 | 68.5 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 3.00 | 66.7 | 66.3 | 67.1 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 4.00 | 64.2 | 63.8 | 64.6 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 5.00 | 62.4 | 61.9 | 62.9 |
All cancers except NMSC (C00-C97 ex C44) | 2009-2013 | cohort | Both | 15-99 | 6.00 | 61.0 | 60.4 | 61.7 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 0.25 | 88.4 | 88.1 | 88.6 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 0.50 | 83.6 | 83.4 | 83.9 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 0.75 | 80.2 | 79.9 | 80.5 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 1.00 | 77.4 | 77.1 | 77.7 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 1.50 | 73.3 | 72.9 | 73.6 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 2.00 | 70.4 | 70.0 | 70.7 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 2.50 | 68.2 | 67.9 | 68.5 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 3.00 | 66.7 | 66.4 | 67.1 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 4.00 | 64.2 | 63.8 | 64.6 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 5.00 | 62.4 | 62.0 | 62.8 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 6.00 | 60.9 | 60.5 | 61.3 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 7.00 | 59.9 | 59.4 | 60.3 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 8.00 | 59.3 | 58.8 | 59.8 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 9.00 | 58.8 | 58.3 | 59.4 |
All cancers except NMSC (C00-C97 ex C44) | 2010-2014 | hybrid | Both | 15-99 | 10.00 | 58.5 | 57.9 | 59.2 |